Prion-like α-synuclein pathology in the brain of infants with Krabbe disease

Christopher Hatton1,2, Simona S Ghanem3, David J Koss2

  • 1Wellcome Centre for Mitochondrial Research, Claremont Road, Newcastle NE2 4AA, UK.

Insights

Krabbe disease, a neurodegenerative disorder, shows prion-like alpha-synuclein accumulation in infants, similar to Lewy body disease. This suggests alpha-synuclein pathology arises from metabolic pathway alterations, not just aging.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Krabbe disease is an infantile neurodegenerative disorder caused by GALC gene variants, leading to toxic psychosine accumulation.
  • GALC variants are also linked to Lewy body diseases, characterized by alpha-synuclein aggregation.

Purpose of the Study:

  • To investigate pathological similarities of alpha-synuclein in Krabbe disease brain tissue compared to Lewy body disease.
  • To determine if alpha-synuclein in Krabbe disease exhibits disease-associated pathogenic properties.

Main Methods:

  • Observational post-mortem study of Krabbe disease brain tissue (n=4) and infant controls (n=4).
  • Evaluation of alpha-synuclein seeding capacity using real-time quaking-induced conversion (RT-QuIC) assay on available frozen tissue.

Main Results:

  • Widespread alpha-synuclein accumulations were identified in Krabbe disease infant brains.
  • Krabbe disease-derived alpha-synuclein demonstrated prion-like aggregation into fibrils, similar to Lewy body disease.

Conclusions:

  • This is the first report of prion-like alpha-synuclein in infant brains.
  • Alpha-synuclein pathology may result from altered biological pathways like sphingolipid metabolism, challenging the age-associated view.
  • Findings impact understanding of Lewy body formation mechanisms.